Transdermal Testosterone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240976

Publication Date:

September 6, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
The global market for Transdermal Testosterone was estimated to be worth US$ 589 million in 2023 and is forecast to a readjusted size of US$ 923.9 million by 2030 with a CAGR of 7.4% during the forecast period 2024-2030
North American market for Transdermal Testosterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Testosterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Transdermal Testosterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Transdermal Testosterone include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Testosterone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Transdermal Testosterone by region & country, by Type, and by Application.
The Transdermal Testosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Testosterone.
Market Segmentation
By Company
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
Segment by Type:
Gel
Patch
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Transdermal Testosterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Transdermal Testosterone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Transdermal Testosterone Product Introduction
1.2 Global Transdermal Testosterone Market Size Forecast
1.2.1 Global Transdermal Testosterone Sales Value (2019-2030)
1.2.2 Global Transdermal Testosterone Sales Volume (2019-2030)
1.2.3 Global Transdermal Testosterone Sales Price (2019-2030)
1.3 Transdermal Testosterone Market Trends & Drivers
1.3.1 Transdermal Testosterone Industry Trends
1.3.2 Transdermal Testosterone Market Drivers & Opportunity
1.3.3 Transdermal Testosterone Market Challenges
1.3.4 Transdermal Testosterone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transdermal Testosterone Players Revenue Ranking (2023)
2.2 Global Transdermal Testosterone Revenue by Company (2019-2024)
2.3 Global Transdermal Testosterone Players Sales Volume Ranking (2023)
2.4 Global Transdermal Testosterone Sales Volume by Company Players (2019-2024)
2.5 Global Transdermal Testosterone Average Price by Company (2019-2024)
2.6 Key Manufacturers Transdermal Testosterone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Transdermal Testosterone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Testosterone
2.9 Transdermal Testosterone Market Competitive Analysis
2.9.1 Transdermal Testosterone Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Testosterone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Testosterone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gel
3.1.2 Patch
3.2 Global Transdermal Testosterone Sales Value by Type
3.2.1 Global Transdermal Testosterone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Transdermal Testosterone Sales Value, by Type (2019-2030)
3.2.3 Global Transdermal Testosterone Sales Value, by Type (%) (2019-2030)
3.3 Global Transdermal Testosterone Sales Volume by Type
3.3.1 Global Transdermal Testosterone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Transdermal Testosterone Sales Volume, by Type (2019-2030)
3.3.3 Global Transdermal Testosterone Sales Volume, by Type (%) (2019-2030)
3.4 Global Transdermal Testosterone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Primary Hypogonadism
4.1.2 Hypogonadotropic Hypogonadism
4.1.3 Late-Onset Hypogonadism
4.2 Global Transdermal Testosterone Sales Value by Application
4.2.1 Global Transdermal Testosterone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Transdermal Testosterone Sales Value, by Application (2019-2030)
4.2.3 Global Transdermal Testosterone Sales Value, by Application (%) (2019-2030)
4.3 Global Transdermal Testosterone Sales Volume by Application
4.3.1 Global Transdermal Testosterone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Transdermal Testosterone Sales Volume, by Application (2019-2030)
4.3.3 Global Transdermal Testosterone Sales Volume, by Application (%) (2019-2030)
4.4 Global Transdermal Testosterone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Transdermal Testosterone Sales Value by Region
5.1.1 Global Transdermal Testosterone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Transdermal Testosterone Sales Value by Region (2019-2024)
5.1.3 Global Transdermal Testosterone Sales Value by Region (2025-2030)
5.1.4 Global Transdermal Testosterone Sales Value by Region (%), (2019-2030)
5.2 Global Transdermal Testosterone Sales Volume by Region
5.2.1 Global Transdermal Testosterone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Transdermal Testosterone Sales Volume by Region (2019-2024)
5.2.3 Global Transdermal Testosterone Sales Volume by Region (2025-2030)
5.2.4 Global Transdermal Testosterone Sales Volume by Region (%), (2019-2030)
5.3 Global Transdermal Testosterone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Transdermal Testosterone Sales Value, 2019-2030
5.4.2 North America Transdermal Testosterone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Transdermal Testosterone Sales Value, 2019-2030
5.5.2 Europe Transdermal Testosterone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Transdermal Testosterone Sales Value, 2019-2030
5.6.2 Asia Pacific Transdermal Testosterone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Transdermal Testosterone Sales Value, 2019-2030
5.7.2 South America Transdermal Testosterone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Transdermal Testosterone Sales Value, 2019-2030
5.8.2 Middle East & Africa Transdermal Testosterone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transdermal Testosterone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Transdermal Testosterone Sales Value
6.2.1 Key Countries/Regions Transdermal Testosterone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Transdermal Testosterone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Transdermal Testosterone Sales Value, 2019-2030
6.3.2 United States Transdermal Testosterone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Transdermal Testosterone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Transdermal Testosterone Sales Value, 2019-2030
6.4.2 Europe Transdermal Testosterone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Transdermal Testosterone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Transdermal Testosterone Sales Value, 2019-2030
6.5.2 China Transdermal Testosterone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Transdermal Testosterone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Transdermal Testosterone Sales Value, 2019-2030
6.6.2 Japan Transdermal Testosterone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Transdermal Testosterone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Transdermal Testosterone Sales Value, 2019-2030
6.7.2 South Korea Transdermal Testosterone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Transdermal Testosterone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Transdermal Testosterone Sales Value, 2019-2030
6.8.2 Southeast Asia Transdermal Testosterone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Transdermal Testosterone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Transdermal Testosterone Sales Value, 2019-2030
6.9.2 India Transdermal Testosterone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Transdermal Testosterone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Introduction and Business Overview
7.1.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie Transdermal Testosterone Product Offerings
7.1.5 AbbVie Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Introduction and Business Overview
7.2.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Teva Transdermal Testosterone Product Offerings
7.2.5 Teva Recent Development
7.3 Perrigo
7.3.1 Perrigo Company Information
7.3.2 Perrigo Introduction and Business Overview
7.3.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Perrigo Transdermal Testosterone Product Offerings
7.3.5 Perrigo Recent Development
7.4 Endo Pharmaceuticals
7.4.1 Endo Pharmaceuticals Company Information
7.4.2 Endo Pharmaceuticals Introduction and Business Overview
7.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Endo Pharmaceuticals Transdermal Testosterone Product Offerings
7.4.5 Endo Pharmaceuticals Recent Development
7.5 Acerus Pharmaceuticals
7.5.1 Acerus Pharmaceuticals Company Information
7.5.2 Acerus Pharmaceuticals Introduction and Business Overview
7.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Acerus Pharmaceuticals Transdermal Testosterone Product Offerings
7.5.5 Acerus Pharmaceuticals Recent Development
7.6 Lupin
7.6.1 Lupin Company Information
7.6.2 Lupin Introduction and Business Overview
7.6.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Lupin Transdermal Testosterone Product Offerings
7.6.5 Lupin Recent Development
7.7 Dr. Reddy's Laboratories
7.7.1 Dr. Reddy's Laboratories Company Information
7.7.2 Dr. Reddy's Laboratories Introduction and Business Overview
7.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Product Offerings
7.7.5 Dr. Reddy's Laboratories Recent Development
7.8 Upsher-Smith Laboratories
7.8.1 Upsher-Smith Laboratories Company Information
7.8.2 Upsher-Smith Laboratories Introduction and Business Overview
7.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Upsher-Smith Laboratories Transdermal Testosterone Product Offerings
7.8.5 Upsher-Smith Laboratories Recent Development
7.9 Allergan
7.9.1 Allergan Company Information
7.9.2 Allergan Introduction and Business Overview
7.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Allergan Transdermal Testosterone Product Offerings
7.9.5 Allergan Recent Development
7.10 Cipla Inc.
7.10.1 Cipla Inc. Company Information
7.10.2 Cipla Inc. Introduction and Business Overview
7.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Cipla Inc. Transdermal Testosterone Product Offerings
7.10.5 Cipla Inc. Recent Development
8 Industry Chain Analysis
8.1 Transdermal Testosterone Industrial Chain
8.2 Transdermal Testosterone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transdermal Testosterone Sales Model
8.5.2 Sales Channel
8.5.3 Transdermal Testosterone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂